Purpose: Angiotensin converting–enzyme (ACE) inhibitors decrease mortality after
myocardial infarction among patients with depressed left ventricular function. Beta blockers …

We sought to determine how often angiotensin-converting enzyme (ACE) inhibitors are
prescribed as a discharge medication among eligible patients≥ 65 years old with an acute …

Persons with asymptomatic left ventricular (LV) systolic dysfunction after myocardial
infarction treated with blockers1, 2 or with angiotensin-converting enzyme (ACE) inhibitors3 …

Background: Several randomized, controlled trials show that angiotensin-converting enzyme
(ACE) inhibitors improve survival in patients who have had an acute myocardial infarction …

In contrast to systolic dysfunction, there are no large randomized trials that identify a therapy
that improves survival in patients with heart failure (HF) due to diastolic dysfunction. We …

Background The benefit of angiotensin-converting enzyme (ACE) inhibitors on mortality in
heart failure has been proved in randomized controlled trials. Methods We prospectively …

Background Despite randomized controlled trials demonstrating mortality reduction, many
studies have documented persistent low rates of prescription of angiotensin-converting …

Background—Although ACE inhibitors are underprescribed for heart failure, factors
associated with their use are not well described. Furthermore, the effectiveness of ACE …

Background—The elderly constitute an increasing proportion of acute myocardial infarction
patients and have disproportionately high mortality and morbidity. Those with heart failure or …

Background We sought to describe the dosages of angiotensin-converting enzyme (ACE)
inhibitor prescribed to elderly patients with heart failure at hospital discharge, the factors …